By: Angela Schab, Amanda Compadre, Rebecca Drexler, Ian S. Hagemann, Ann E. Walts, Beth Y. Karlan, Sandra Orsulic, Katherine C. Fuh, Priyanka Verma, Elena Lomonosova, Peinan Zhao, Dineo Khabele
BACKGROUND. Treatment of tubo-ovarian high-grade serous carcinoma (HGSC) includes cytoreductive surgery, platinum-based chemotherapy, and often poly(ADP-ribose) polymerase (PARP) inhibitors.



